Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Review

Research Support, Non-U.S. Gov't

Comparative Study

Multicenter Study

Clinical Trial, Phase III

Comment

Clinical Trial

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2025

2023

2022

2021

2020

2017

2016

2015

2014

2013

2012

2011

2008

2007

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Serotonin 5-HT1 Receptor Agonists""[mesh_terms]

20 Results

Searching titles within these results

Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea.

Chiara Benedetto, Ilaria Castagnoli Gabellari, Sara Rolando, Gianni Allais

Expert review of neurotherapeutics 2012;11(10):1383-7

Full Text

Abstract

Drug Treatment of Cluster Headache.

Hans Christoph Diener, Arne May

Drugs 2022;82(1):33-42

Free Full Text

Abstract

Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register.

Peer Carsten Tfelt-Hansen

The journal of headache and pain 2011;12(4):399-403

Free Full Text

Abstract

A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open-label extension.

Marcy E Yonker, Jennifer McVige, Leonid Zeitlin, Hester Visser

Headache 2022;62(9):1207-1217

Full Text

Abstract

Effect of sumatriptan on ATP-sensitive potassium channel opening in migraine: A randomised controlled trial.

Mohammad Al-Mahdi Al-Karagholi, Håkan Ashina, Zixuan Alice Zhuang, Messoud Ashina, Thien Phu Do

Cephalalgia : an international journal of headache 2025;45(7):3331024251341464

Free Full Text

Abstract

Targeting the 5-HT and 5-HT receptors for acute migraine treatment.

Pin-Chung Huang, Fu-Chi Yang, Ching-Mao Chang, Chun-Pai Yang

Progress in brain research 2021;255():99-121

Full Text

Abstract

SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.

Roger Cady, Phillip O'Carroll, Kent Dexter, Fred Freitag, Candace L Shade

Headache 2014;54(1):67-79

Full Text

Abstract

PET tracers for 5-HT(1A) receptors and uses thereof.

J John Mann, J S Dileep Kumar

Drug discovery today 2008;12(17-18):748-56

Full Text

Abstract

Non-CGRP Antagonist/Non-Triptan Options for Migraine Disease Treatment: Clinical Considerations.

Elisa E Neuchat, Shahab Ahmadzadeh, Sahar Shekoohi, Ellen E Ingram, Brooke E Bocklud, Sarah C Corley, Mallory A Granier, Alan D Kaye

Current pain and headache reports 2023;27(10):497-502

Full Text

Abstract

Pharmacological synergy: the next frontier on therapeutic advancement for migraine.

Chris Gennings, Roger Cady, Andrew Blumenfeld

Headache 2012;52(4):636-47

Full Text

Abstract

Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.

Roger Cady, Robert Nett, Kent Dexter, Fred Freitag, M E Beach, Heather R Manley

Headache 2014;54(1):80-93

Full Text

Abstract

Triptan-induced disruption of trigemino-cortical connectivity.

Inga L Kröger, Arne May

Neurology 2015;84(21):2124-31

Full Text

Abstract

Sumatriptan-naproxen migraine efficacy in allodynic patients: early intervention.

Stephen Landy, Rebecca Hoagland, Nancy A Hoagland

Headache 2012;52(1):133-9

Full Text

Abstract

Sumatriptan/naproxen sodium: a review of its use in adult patients with migraine.

Lily P H Yang

Drugs 2014;73(12):1339-55

Full Text

Abstract

Consistency of response to sumatriptan/naproxen sodium in a randomized placebo-controlled, cross-over study for the acute treatment of migraine in adolescence.

Paul Winner, Steven Linder, Andrew D Hershey

Headache 2016;55(4):519-28

Full Text

Abstract

Results: 1 – 15 / 20

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Serotonin 5-HT1 Receptor Agonists""[mesh_terms]

Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea.

Drug Treatment of Cluster Headache.

Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register.

A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open-label extension.

Effect of sumatriptan on ATP-sensitive potassium channel opening in migraine: A randomised controlled trial.

Targeting the 5-HT and 5-HT receptors for acute migraine treatment.

SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.

PET tracers for 5-HT(1A) receptors and uses thereof.

Non-CGRP Antagonist/Non-Triptan Options for Migraine Disease Treatment: Clinical Considerations.

Pharmacological synergy: the next frontier on therapeutic advancement for migraine.

Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.

Triptan-induced disruption of trigemino-cortical connectivity.

Sumatriptan-naproxen migraine efficacy in allodynic patients: early intervention.

Sumatriptan/naproxen sodium: a review of its use in adult patients with migraine.

Consistency of response to sumatriptan/naproxen sodium in a randomized placebo-controlled, cross-over study for the acute treatment of migraine in adolescence.

Results for
""Serotonin 5-HT1 Receptor Agonists""[mesh_terms]